Jazz Pharmaceuticals plc JAZZ was a big mover last session with its shares rising over 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend of the company as the stock has lost nearly 9% in the past one-month time frame.
This specialty biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Jazz Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs industry may consider stocks like Endo International plc ENDP, Endocyte, Inc. ECYT and Salix Pharmaceuticals Ltd. SLXP. All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
This specialty biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Jazz Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs industry may consider stocks like Endo International plc ENDP, Endocyte, Inc. ECYT and Salix Pharmaceuticals Ltd. SLXP. All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
JAZZ PHARMACEUT JAZZ: Free Stock Analysis Report
ENDO INTL PLC ENDP: Free Stock Analysis Report
ENDOCYTE INC ECYT: Free Stock Analysis Report
SALIX PHARM-LTD SLXP: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Movers & ShakersGeneral
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
